Missing Cases of Herpes Simplex Virus (HSV) Infection of the Central Nervous System When the Reller Criteria Are Applied for HSV PCR Testing: a Multicenter Study.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
02 2019
Historique:
received: 25 10 2018
accepted: 19 11 2018
pubmed: 30 11 2018
medline: 2 4 2020
entrez: 30 11 2018
Statut: epublish

Résumé

Previous studies suggested that herpes simplex virus (HSV) PCR testing can be safely deferred in patients with normal cerebrospinal fluid (CSF) white blood cell (WBC) counts and protein levels as long as they are older than 2 years of age and are not immunocompromised, the so-called Reller criteria. In this multicenter study, we retrospectively assessed the validity of these screening criteria in our setting. A total of 4,404 CSF specimens submitted for HSV PCR testing to the respective microbiology laboratories at the participating hospitals between 2012 and 2018 were included. Six commercially available HSV PCR assays were used across the participating centers. Ninety-one of the 4,404 CSF specimens (2.1%) tested were positive for HSV DNA (75 samples for HSV-1 and 16 for HSV-2). Nine patients failed to meet the Reller criteria, of whom seven were deemed to truly have HSV encephalitis. Overall, no significant correlation between HSV PCR cycle threshold (

Identifiants

pubmed: 30487303
pii: JCM.01719-18
doi: 10.1128/JCM.01719-18
pmc: PMC6355537
pii:
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

BMJ. 2008 Jan 5;336(7634):36-40
pubmed: 18174598
J Pathol Inform. 2017 Feb 28;8:4
pubmed: 28400993
Neurotherapeutics. 2016 Jul;13(3):493-508
pubmed: 27106239
J Infect. 2012 May;64(5):449-77
pubmed: 22120594
BMC Res Notes. 2016 Feb 15;9:95
pubmed: 26879928
J Infect. 2012 Apr;64(4):347-73
pubmed: 22120595
J Clin Microbiol. 2007 Mar;45(3):721-4
pubmed: 17202281
Clin Infect Dis. 2008 Aug 1;47(3):303-27
pubmed: 18582201
Neuroimaging Clin N Am. 2008 Feb;18(1):53-84; viii
pubmed: 18319155
J Clin Microbiol. 2017 Oct;55(10):3144-3145
pubmed: 28947510
Enferm Infecc Microbiol Clin. 2009 Mar;27(3):143-7
pubmed: 19306713
J Clin Microbiol. 2017 May;55(5):1566-1575
pubmed: 28298450
J Clin Virol. 2018 Oct;107:29-37
pubmed: 30170224
Antimicrob Agents Chemother. 2015;59(6):3084-9
pubmed: 25779579
Clin Infect Dis. 2013 Oct;57(8):1114-28
pubmed: 23861361
J Clin Microbiol. 2017 Oct;55(10):3142-3143
pubmed: 28947509
Intervirology. 2014;57(1):1-7
pubmed: 23988484
J Clin Microbiol. 2013 Sep;51(9):2880-3
pubmed: 23804382
Clin Infect Dis. 2002 Aug 15;35(4):414-9
pubmed: 12145725
Clin Infect Dis. 1999 Oct;29(4):803-6
pubmed: 10589893
Diagn Microbiol Infect Dis. 2013 Nov;77(3):236-40
pubmed: 24035384
Int J Infect Dis. 2017 Dec;65:107-109
pubmed: 29081366

Auteurs

Eliseo Albert (E)

Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia, Spain.

Juan Alberola (J)

Microbiology Service, Hospital Universitario Doctor Peset, Valencia, Spain.

Monserrat Bosque (M)

Microbiology Service, Hospital Arnau de Vilanova, Valencia, Spain.

Juan José Camarena (JJ)

Microbiology Service, Hospital Universitario Doctor Peset, Valencia, Spain.

María Ángeles Clari (MÁ)

Microbiology Unit, Hospital Francesc de Borja, Gandía, Spain.

María Victoria Domínguez Márquez (MV)

Microbiology Service, Hospital Arnau de Vilanova, Valencia, Spain.

María Gil-Fortuño (M)

Microbiology Service, Hospital General Universitario, Castellón de la Plana, Spain.

Adelina Gimeno (A)

Microbiology Service, Hospital General Universitario, Alicante, Spain.

José Miguel Nogueira (JM)

Microbiology Service, Hospital Universitario Doctor Peset, Valencia, Spain.

María Dolores Ocete (MD)

Microbiology Service, Consorcio Hospital General Universitario, Valencia, Spain.

Nieves Orta (N)

Microbiology Unit, Hospital Francesc de Borja, Gandía, Spain.

Josep Prat (J)

Microbiology Unit, Hospital de Sagunto, Valencia, Spain.

Juan Carlos Rodríguez (JC)

Microbiology Service, Hospital General Universitario, Alicante, Spain.

Isabel Valero (I)

Microbiology Service, Consorcio Hospital General Universitario, Valencia, Spain.

Concepción Gimeno Cardona (C)

Microbiology Service, Consorcio Hospital General Universitario, Valencia, Spain.

David Navarro (D)

Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia, Spain david.navarro@uv.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH